[Calcium and phospate metabolism disorders in patients on long-term diphenylhydantoin therapy].
D000293:Adolescent; D000328:Adult; D001842:Bone and Bones / Q000187:drug effects; D002118:Calcium / Q000097:blood*; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced; D008274:Magnesium / Q000097:blood*; D008875:Middle Aged; D010018:Osteomalacia / Q000139:chemically induced; D010672:Phenytoin / Q000009:adverse effects* / Q000627:therapeutic use; D010710:Phosphates / Q000097:blood*; D013997:Time Factors
D010710:Phosphates; D010672:Phenytoin; D008274:Magnesium; D002118:Calcium
Ocena zaburzeń wapniowo-fosforanowych u chorych leczonych przewlekle dwufenylohydantoina.